Automated Author ProfileMarchesoni, Antonio
Marchesoni, Antonio
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 1.0 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
PodcastsThe podcasts above summarise Professor Marchesoni’s commentary article; why not download them to listen to when convenient?
The podcasts are split per section in case there is one particular topic you want to listen to, or please download the full narration to listen to everything in one go.
The podcasts were funded by Celgene Corporation, with support for the development provided by Dr. Nicholas Moss from MediTech Media and the narration provided by piersbishop.com.
Celgene Corporation references: UK-I&I180094(1)d / GLII-CELG180008b.Disclosures
Dr. A. Marchesoni has received honoraria and speaker fees from AbbVie, BMS, Celgene, Janssen, MSD, Novartis, Pfizer, and UCB.Compliance with Ethics Guidelines
This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.Copyright
Full copyright for enhanced digital features is owned by Celgene Corporation.
Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s40744-018-0115-5
Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact [email protected].
The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.
Other enhanced features include, but are not limited to:
• Slide decks
• Videos and animations • Audio abstracts • Audio slides
Authors
- Marchesoni, Antonio
PodcastsThe podcasts above summarise Professor Marchesoni’s commentary article; why not download them to listen to when convenient?
The podcasts are split per section in case there is one particular topic you want to listen to, or please download the full narration to listen to everything in one go.
The podcasts were funded by Celgene Corporation, with support for the development provided by Dr. Nicholas Moss from MediTech Media and the narration provided by piersbishop.com.
Celgene Corporation references: UK-I&I180094(1)d / GLII-CELG180008b.Disclosures
Dr. A. Marchesoni has received honoraria and speaker fees from AbbVie, BMS, Celgene, Janssen, MSD, Novartis, Pfizer, and UCB.Compliance with Ethics Guidelines
This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.Copyright
Full copyright for enhanced digital features is owned by Celgene Corporation.
Article full text The full text of this article can be found here. https://link.springer.com/article/10.1007/s40744-018-0115-5
Provide enhanced content for this article If you are an author of this publication and would like to provide additional enhanced content for your article then please contact [email protected].
The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.
Other enhanced features include, but are not limited to:
• Slide decks
• Videos and animations • Audio abstracts • Audio slides
Authors
- Marchesoni, Antonio